Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Tuberous Sclerosis 6 Seizures 5 Marijuana Abuse 3 Lennox Gastaut Syndrome 3 Epilepsies, Myoclonic 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sturge-Weber Syndrome 2 Neoplasms 2 Nausea 2 Glioblastoma 2 Anxiety Disorders 2 Vomiting 1 Tuberous Sclerosis 2 1 Tuberous Sclerosis 1 1 Spasms, Infantile 1 Solid Tumor 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Parasomnias 1 Pancreatic Neoplasms 1 Pain 1 Multiple Myeloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Gallbladder Neoplasms 1 Epilepsy 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 14 Injections 13 Paclitaxel 10 Nivolumab 10 Docetaxel 9 Cisplatin 9 Capecitabine 9 Bevacizumab 8 toripalimab 7 senaparib 7 Fluorodeoxyglucose F18 7 Cyclophosphamide 7 tislelizumab 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 Gemcitabine 5 fludarabine 4 apatinib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Carboplatin 4 spartalizumab 3 sintilimab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Cannabidiol × Clear all

NCT02255292 2014-10-02

A Study: Pure CBD as Single-agent for Solid Tumor.

Hadassah Medical Organization

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡